Transient silencing of Npr3 gene expression improved the circulatory levels of atrial natriuretic peptides and attenuated β-adrenoceptor activation- induced cardiac hypertrophic growth in experimental rats

European Journal of Pharmacology

Volumn 782, Issue , 2016, Pages 44-58

  Venkatesan, Balaji ^a   Tumala, Anusha ^a   Subramanian, Vimala ^a   Vellaichamy, Elangovan ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Atrial natriuretic peptide; Cardiac hypertrophy; Gene silencing; Natriuretic peptide receptor C; Adrenoceptor agonist isoproterenol

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BETA ADRENERGIC RECEPTOR; CATALASE; COLLAGEN; CREATINE KINASE; CREATINE KINASE MB; GELATINASE A; LACTATE DEHYDROGENASE; MESSENGER RNA; MYOSIN HEAVY CHAIN BETA; NATRIURETIC PEPTIDE RECEPTOR C; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; SUPEROXIDE DISMUTASE; ATRIAL NATRIURETIC FACTOR RECEPTOR; BIOLOGICAL MARKER;

ALPHA SKELETAL MUSCLE GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA MYOSIN HEAVY CHAIN GENE; CARDIAC MYOBLAST; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE SILENCING; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT TO BODY WEIGHT RATIO; MALE; MARKER GENE; NONHUMAN; NPR3 GENE; ONCOGENE C FOS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; BLOOD; CELL LINE; DEFICIENCY; GENETICS; HEART VENTRICLE; METABOLISM; PATHOLOGY;

ANIMALS; ATRIAL NATRIURETIC FACTOR; BIOMARKERS; CELL LINE; COLLAGEN; DOWN-REGULATION; GENE SILENCING; HEART VENTRICLES; MALE; MATRIX METALLOPROTEINASE 2; RATS; REACTIVE OXYGEN SPECIES; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, ATRIAL NATRIURETIC FACTOR; RNA, SMALL INTERFERING;

EID: 84964621562     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2016.04.037     Document Type: Article

References (61)

1. M.G. Andreassi, S. Del Ry, C. Palmieri, A. Clerico, A. Biagini, and D. Giannessi Up-regulation of 'clearance'receptors in patients with chronic heart failure: a possible explanation for the resistance to biological effects of cardiac natriuretic hormones Eur. J. Heart Fail. 3 4 2001 407 414
2. V. Balan, and L. Verestiuc Strategies to improve chitosan hemocompatibility: a review Eur. Polym. J. 53 2014 171 188
3. I. Bergman, and R. Loxley Two improved and simplified methods for the spectrophotometric determination of hydroxyproline Anal. Chem. 35 12 1963 1961 1965
4. M.S. Chang, D.G. Lowe, M. Lewis, R. Hellmiss, E. Chen, and D.V. Goeddel Differential activation by atrial and brain natriuretic peptides of two different receptor guanylate cyclases Nature 7 341 1989 68 72
5. C.J. Charles, E.A. Espiner, M.G. Nicholls, A.M. Richards, T.G. Yandle, A.N.D.Y. Protter, and T.E.D.D.Y. Kosoglou Clearance receptors and endopeptidase 24.11: equal role in natriuretic peptide metabolism in conscious sheep Am. J. Physiol. Regul. Integr. Comp. Physiol. 271 2 1996 R373 R380
6. T.E. Christoffersen, M. Aplin, C.C. Strom, S.P. Sheikh, O. Skott, P.K. Busk, S. Haunso, and L.B. Nielsen Increased natriuretic peptide receptor A and C gene expression in rats with pressure-overload cardiac hypertrophy Am. J. Physiol. Heart Circ. Physiol. 290 4 2006 H1635 H1641
7. I.L. Ennis, E.M. Escudero, G.M. Console, G. Camihort, C.G. Dumm, R.W. Seidler, M.C.C. de Hurtado, and H.E. Cingolani Regression of isoproterenol-induced cardiac hypertrophy by Na+/H+exchanger inhibition Hypertension 41 6 2003 1324 1329
8. F. Fuller, J.G. Porter, A.E. Arfsten, J. Miller, J.W. Schilling, R.M. Scarborough, J.A. Lewicki, and D.B. Schenk Atrial natriuretic peptide clearance receptor. Complete sequence and functional expression of cDNA clones J. Biol. Chem. 263 19 1988 9395 9401
9. M.M. Givertz, D.B. Sawyer, and W.S. Colucci Antioxidants and myocardial contractility illuminating the "dark side" of β-adrenergic receptor activation? Circulation 103 6 2001 782 783
10. V. Gopi, A. Parthasarathy, S. Umadevi, and E. Vellaichamy Angiotensin-II down-regulates cardiac natriuretic peptide receptor-A mediated anti-hypertrophic signaling in experimental rat hearts Indian J. Exp. Biol. 51 2013 48 55
11. R.J. Guzman, P. Lemarchand, R.G. Crystal, S.E. Epstein, and T. Finkel Efficient gene transfer into myocardium by direct injection of adenovirus vectors Circ. Res. 73 6 1993 1202 1207
12. B. Halliwell Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 344 8924 1994 721 724
13. L.C. Heather, A.F. Catchpole, D.J. Stuckey, M.A. Cole, C.A. Carr, and K. Clarke Isoproterenol induces in vivo functional and metabolic abnormalities; similar to those found in the infarcted rat heart Acta Physiol. Pol. 12 3 2009 31 39
14. R. Holtwick, M. van Eickels, B.V. Skryabin, H.A. Baba, A. Bubikat, F. Begrow, M.D. Schneider, D.L. Garbers, and M. Kuhn Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A J. Clin. Invest. 111 9 2003 1399 1407
15. K.A. Howard, S.R. Paludan, M.A. Behlke, F. Besenbacher, B. Deleuran, and J. Kjems Chitosan/siRNA nanoparticle-mediated TNF-α knockdown in peritoneal macrophages for anti-inflammatory treatment in a murine arthritis model Mol. Ther. 17 1 2009 162 168
16. Y. Iwanaga, T. Aoyama, Y. Kihara, Y. Onozawa, T. Yoneda, and S. Sasayama Excessive activation of matrix metalloproteinases coincides with left ventricular remodeling during transition from hypertrophy to heart failure in hypertensive rats J. Am. Coll. Cardiol. 39 8 2002 1384 1391
17. J.E. Jalil, C.W. Doering, J.S. Janicki, R. Pick, S.G. Shroff, and K.T. Weber Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle Circ. Res. 64 6 1989 1041 1050
18. I. Kishimoto, T. Tokudome, T. Horio, D.L. Garbers, K. Nakao, and K. Kangawa Natriuretic peptide signaling via guanylyl cyclase (GC)-A: an endogenous protective mechanism of the heart Curr. Cardiol. Rev. 5 1 2009 45 51
19. M. Kuhn Molecular physiology of natriuretic peptide signalling Basic Res. Cardiol. 99 2 2004 76 82
20. M. Kuhn, M. Voß, D. Mitko, J. Stypmann, C. Schmid, N. Kawaguchi, F. Grabellus, and H.A. Baba Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure Cardiovasc. Res. 64 2 2004 308 314
21. P. Kumar, G. Bolden, K. Arise, S. Krazit, and K. Pandey Regulation of natriuretic peptide receptor-A gene expression and stimulation of its guanylate cyclase activity by transcription factor Ets-1 Biosci. Rep. 29 2009 57 70
22. A. Laskowski, O.L. Woodman, A.H. Cao, G.R. Drummond, T. Marshall, D.M. Kaye, and R.H. Ritchie Antioxidant actions contribute to the antihypertrophic effects of atrial natriuretic peptide in neonatal rat cardiomyocytes Cardiovasc. Res. 72 1 2006 112 123
23. C.P. LeBel, H. Ischiropoulos, and S.C. Bondy Evaluation of the probe 2′, 7′-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress Chem. Res. Toxicol. 5 2 1992 227 231
24. D.W. Lee, K. Powers, and R. Baney Physicochemical properties and blood compatibility of acylated chitosan nanoparticles Carbohydr. Polym. 58 4 2004 371 377
25. Y. Li, O. Sarkar, M. Brochu, and M.B. Anand-Srivastava Natriuretic peptide receptor-C attenuates hypertension in spontaneously hypertensive rats role of nitroxidative stress and Gi proteins Hypertension 63 4 2014 846 855
26. H. Lin, M.S. Parmacek, G. Morle, S. Bolling, and J.M. Leiden Expression of recombinant genes in myocardium in vivo after direct injection of DNA Circulation 82 6 1990 2217 2221
27. M.J. Lopez, S.K.F. Wong, I. Kishimoto, S. Dubois, V. Mach, J. Friesen, D.L. Garbers, and A. Beuve Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide Nature 378 1995 65 68
28. T. Maack, M. Suzuki, F.A. Almeida, D. Nussenzveig, R.M. Scarborough, G.A. McEnroe, and J.A. Lewicki Physiological role of silent receptors of atrial natriuretic factor Science 238 4827 1987 675 678
29. T. Maki, T. Horio, F. Yoshihara, S.I. Suga, S. Takeo, H. Matsuo, and K. Kangawa Effect of neutral endopeptidase inhibitor on endogenous atrial natriuretic peptide as a paracrine factor in cultured cardiac fibroblasts Br. J. Pharmacol. 131 6 2000 1204 1210
30. S. Marklund, and G. Marklund Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase Eur. J. Biochem. 47 3 1974 469 474
31. N. Matsukawa, W.J. Grzesik, N. Takahashi, K.N. Pandey, S. Pang, M. Yamauchi, and O. Smithies The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system Proc. Natl. Acad. Sci. 96 13 1999 7403 7408
32. S.K. Maulik, P. Prabhakar, A.K. Dinda, and S. Seth Genistein prevents isoproterenol-induced cardiac hypertrophy in rats Can. J. Physiol. Pharmacol. 90 8 2012 1117 1125
33. S. Miura, I. Ohno, J. Suzuki, K. Suzuki, S. Okada, A. Okuyama, J. Nawata, J. Ikeda, and K. Shirato Inhibition of matrix metalloproteinases prevents cardiac hypertrophy induced by β-adrenergic stimulation in rats J. Cardiovasc. Pharmacol. 42 2 2003 174 181
34. E.J. Nielsen, J.M. Nielsen, D. Becker, A. Karlas, H. Prakash, S.Z. Glud, J. Merrison, F. Besenbacher, T.F. Meyer, J. Kjems, and K.A. Howard Pulmonary gene silencing in transgenic EGFP mice using aerosolised chitosan/siRNA nanoparticles Pharm. Res. 27 12 2010 2520 2527
35. C. Nirmala, and R. Puvanakrishnan Protective role of curcumin against isoproterenol induced myocardial infarction in rats Mol. Cell. Biochem. 159 2 1996 85 93
36. P.M. Oliver, J.E. Fox, R. Kim, H.A. Rockman, H.S. Kim, R.L. Reddick, K.N. Pandey, S.L. Milgram, O. Smithies, and N. Maeda Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A Proc. Natl. Acad. Sci. 94 26 1997 14730 14735
37. K.N. Pandey Biology of natriuretic peptides and their receptors Peptides 26 6 2005 901 932
38. K.N. Pandey Guanylylcyclase/atrial natriuretic peptide receptor-A: role in the pathophysiology of cardiovascular regulation Can. J. Physiol. Pharmacol. 89 8 2011 557 573
39. A. Parthasarathy, V. Gopi, K.M.S. Devi, N. Balaji, and E. Vellaichamy Aminoguanidine inhibits ventricular fibrosis and remodeling process in isoproterenol-induced hypertrophied rat hearts by suppressing ROS and MMPs Life Sci. 118 1 2014 15 26
40. A. Parthasarathy, V. Gopi, S. Umadevi, A. Simna, M.J.Y. Sheik, H. Divya, and E. Vellaichamy Suppression of atrial natriuretic peptide/natriuretic peptide receptor-A-mediated signaling upregulates angiotensin-II-induced collagen synthesis in adult cardiac fibroblasts Mol. Cell. Biochem. 378 1-2 2013 217 228
41. R. Pick, J.E. Jalil, J.S. Janicki, and K.T. Weber The fibrillar nature and structure of isoproterenol-induced myocardial fibrosis in the rat Am. J. Pathol. 134 2 1989 365 371
42. D.H. Priscilla, and P.S.M. Prince Cardioprotective effect of gallic acid on cardiac troponin-T, cardiac marker enzymes, lipid peroxidation products and antioxidants in experimentally induced myocardial infarction in Wistar rats Chem. Biol. Interact. 179 2 2009 118 124
43. S. Rajan, J. Radhakrishnan, and C. Rajamanickam Direct injection and expression in vivo of full-length cDNA of the cardiac isoform of alpha-2 macroglobulin induces cardiac hypertrophy in the rat heart Basic Res. Cardiol. 98 1 2003 39 49
44. M. Rajappa, and A. Sharma Biomarkers of cardiac injury: an update Angiology 56 6 2005 677 691
45. M. Shono, M. Yoshimura, M. Nakayama, M. Yamamuro, K. Abe, S. Suzuki, Y. Mizuno, S. Sugiyama, Y. Saito, K. Nakao, and H. Yasue Predominant effect of A-type natriuretic peptide on reduction of oxidative stress during the treatment of patients with heart failure Circ. J. 71 7 2007 1040 1046
46. A.K. Sinha Colorimetric assay of catalase Anal. Biochem. 47 2 1972 389 394
47. I. Somasuntharam, A.V. Boopathy, R.S. Khan, M.D. Martinez, M.E. Brown, N. Murthy, and M.E. Davis Delivery of Nox2-NADPH oxidase siRNA with polyketal nanoparticles for improving cardiac function following myocardial infarction Biomaterials 34 31 2013 7790 7798
48. F.G. Spinale, H. Gunasinghe, P.D. Sprunger, J.M. Baskin, and W.C. Bradham Extracellular degradative pathways in myocardial remodeling and progression to heart failure J. Card. Fail. 8 6 2002 S332 S338
49. V. Subramanian, B. Venkatesan, A. Tumala, and E. Vellaichamy Topical application of Gallic acid suppresses the 7, 12-DMBA/Croton oil induced two-step skin carcinogenesis by modulating anti-oxidants and MMP-2/MMP-9 in Swiss albino mice Food Chem. Toxicol. 66 2014 44 55
50. Si Suga, Kazuwa Nakao, Kiminori Hosoda, Masashi Mukoyama, Yoshihiro Ogawa, Gotaro Shirakami, Hiroshi Arai, Yoshihiko Saito, Yoshikazu Kambayashi, and K. Inouye Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-Type natriuretic peptide Endocrinology 130 1 1992 229 239
51. N. Tamura, Y. Ogawa, H. Chusho, K. Nakamura, K. Nakao, M. Suda, M. Kasahara, R. Hashimoto, G. Katsuura, M. Mukoyama, and H. Itoh Cardiac fibrosis in mice lacking brain natriuretic peptide Proc. Natl. Acad. Sci. 97 8 2000 4239 4244
52. Y. Tang, M. Wang, X. Le, J. Meng, L. Huang, P. Yu, J. Chen, and P. Wu Antioxidant and cardioprotective effects of Danshensu (3-(3, 4-dihydroxyphenyl)-2-hydroxy-propanoic acid from Salvia miltiorrhiza) on isoproterenol-induced myocardial hypertrophy in rats Phytomedicine 18 12 2011 1024 1030
53. P. Thomes, M. Rajendran, B. Pasanban, and R. Rengasamy Cardioprotective activity of Cladosiphon okamuranus fucoidan against isoproterenol induced myocardial infarction in rats Phytomedicine 18 1 2010 52 57
54. T. Tsutamoto, T. Kanamori, N. Morigami, Y. Sugimoto, O. Yamaoka, and M. Kinoshita Possibility of downregulation of atrial natriuretic peptide receptor coupled to guanylate cyclase in peripheral vascular beds of patients with chronic severe heart failure Circulation 87 1 1993 70 75
55. E. Vellaichamy, N.K. Sommana, and K.N. Pandey Reduced cGMP signaling activates NF-κB in hypertrophied hearts of mice lacking natriuretic peptide receptor-A Biochem. Biophys. Res. Commun. 327 1 2005 106 111
56. Venkatesan, B., Tumala, A., Subramanian, V. and Vellaichamy, E., 2016. Synthesis and characterization of chitosan nanoparticles for in vivo delivery of siRNA-Npr3: Targeting NPR-C expression in the heart. Data in Brief, (submitted for publication).
57. S.J. Watkins, G.M. Borthwick, and H.M. Arthur The H9C2 cell line and primary neonatal cardiomyocyte cells show similar hypertrophic responses in vitro In Vitro Cell. Dev. Biol. Anim. 47 2 2011 125 131
58. J.N. Wilcox, A. Augustine, D.V. Goeddel, and D.G. Lowe Differential regional expression of three natriuretic peptide receptor genes within primate tissues Mol. Cell. Biol. 11 7 1991 3454 3462
59. G.X. Zhang, K. Ohmori, Y. Nagai, Y. Fujisawa, A. Nishiyama, Y. Abe, and S. Kimura Role of AT1 receptor in isoproterenol-induced cardiac hypertrophy and oxidative stress in mice J. Mol. Cell. Cardiol. 42 4 2007 804 811
60. G.X. Zhang, S. Kimura, A. Nishiyama, T. Shokoji, M. Rahman, L. Yao, Y. Nagai, Y. Fujisawa, A. Miyatake, and Y. Abe Cardiac oxidative stress in acute and chronic isoproterenol-infused rats Cardiovasc. Res. 65 1 2005 230 238
61. Y. Zou, I. Komuro, T. Yamazaki, S. Kudoh, H. Uozumi, T. Kadowaki, and Y. Yazaki Both Gs and Gi proteins are critically involved in isoproterenol-induced cardiomyocyte hypertrophy J. Biol. Chem. 274 14 1999 9760 9770